These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10411346)

  • 1. Increased brain-derived neurotrophic factor-containing axons in the basal ganglia of patients with multiple system atrophy.
    Kawamoto Y; Nakamura S; Akiguchi I; Kimura J
    J Neuropathol Exp Neurol; 1999 Jul; 58(7):765-72. PubMed ID: 10411346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in total cell numbers of the basal ganglia in patients with multiple system atrophy - A stereological study.
    Salvesen L; Ullerup BH; Sunay FB; Brudek T; Løkkegaard A; Agander TK; Winge K; Pakkenberg B
    Neurobiol Dis; 2015 Feb; 74():104-13. PubMed ID: 25449905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LRRK2 and parkin immunoreactivity in multiple system atrophy inclusions.
    Huang Y; Song YJ; Murphy K; Holton JL; Lashley T; Revesz T; Gai WP; Halliday GM
    Acta Neuropathol; 2008 Dec; 116(6):639-46. PubMed ID: 18936941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Widespread alterations of alpha-synuclein in multiple system atrophy.
    Dickson DW; Liu W; Hardy J; Farrer M; Mehta N; Uitti R; Mark M; Zimmerman T; Golbe L; Sage J; Sima A; D'Amato C; Albin R; Gilman S; Yen SH
    Am J Pathol; 1999 Oct; 155(4):1241-51. PubMed ID: 10514406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subregional patterns of preferential striatal dopamine transporter loss differ in Parkinson disease, progressive supranuclear palsy, and multiple-system atrophy.
    Oh M; Kim JS; Kim JY; Shin KH; Park SH; Kim HO; Moon DH; Oh SJ; Chung SJ; Lee CS
    J Nucl Med; 2012 Mar; 53(3):399-406. PubMed ID: 22323779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen reduces BDNF level, but maintains dopaminergic cell density in the striatum of MPTP mouse model.
    Tripanichkul W; Gerdprasert O; Jaroensuppaperch EO
    Int J Neurosci; 2010 Jul; 120(7):489-95. PubMed ID: 20583901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease.
    Orimo S; Uchihara T; Nakamura A; Mori F; Kakita A; Wakabayashi K; Takahashi H
    Brain; 2008 Mar; 131(Pt 3):642-50. PubMed ID: 18079166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Midkine, a new neurotrophic factor, is present in glial cytoplasmic inclusions of multiple system atrophy brains.
    Kato S; Shinozawa T; Takikawa M; Kato M; Hirano A; Awaya A; Ohama E
    Acta Neuropathol; 2000 Nov; 100(5):481-9. PubMed ID: 11045670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A quantitative study of the pathological changes in ten patients with multiple system atrophy (MSA).
    Armstrong RA; Cairns NJ; Lantos PL
    J Neural Transm (Vienna); 2004 Apr; 111(4):485-95. PubMed ID: 15057518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased brain histamine levels in Parkinson's disease but not in multiple system atrophy.
    Rinne JO; Anichtchik OV; Eriksson KS; Kaslin J; Tuomisto L; Kalimo H; Röyttä M; Panula P
    J Neurochem; 2002 Jun; 81(5):954-60. PubMed ID: 12065607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calbindin-D28k in the basal ganglia of patients with parkinsonism.
    Ito H; Goto S; Sakamoto S; Hirano A
    Ann Neurol; 1992 Oct; 32(4):543-50. PubMed ID: 1456738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous brain-derived neurotrophic factor protects dopaminergic nigral neurons against transneuronal degeneration induced by striatal excitotoxic injury.
    Canudas AM; Pezzi S; Canals JM; Pallàs M; Alberch J
    Brain Res Mol Brain Res; 2005 Mar; 134(1):147-54. PubMed ID: 15790538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide synthase mRNA expression in human subthalamic nucleus, striatum and globus pallidus: implications for basal ganglia function.
    Nisbet AP; Foster OJ; Kingsbury A; Lees AJ; Marsden CD
    Brain Res Mol Brain Res; 1994 Mar; 22(1-4):329-32. PubMed ID: 7516995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AAV-BDNF mediated attenuation of quinolinic acid-induced neuropathology and motor function impairment.
    Kells AP; Henry RA; Connor B
    Gene Ther; 2008 Jul; 15(13):966-77. PubMed ID: 18323792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of donor age and brain-derived neurotrophic factor on the survival of dopaminergic neurons and axonal growth in postnatal rat nigrostriatal cocultures.
    Ostergaard K; Jones SA; Hyman C; Zimmer J
    Exp Neurol; 1996 Dec; 142(2):340-50. PubMed ID: 8934565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of subcortical atrophy and iron deposition in multiple system atrophy: a comparison between clinical subtypes.
    Lee JH; Kim TH; Mun CW; Kim TH; Han YH
    J Neurol; 2015 Aug; 262(8):1876-82. PubMed ID: 26016683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-DARPP32 antibody-immunopositive inclusions in the brain of patients with multiple system atrophy.
    Honjo Y; Shirakashi Y; Kawamoto Y; Akiguchi I
    Clin Neuropathol; 2008; 27(5):309-16. PubMed ID: 18808062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glial cell line-derived neurotrophic factor-like immunoreactivity in the cerebella of normal subjects and patients with multiple system atrophy.
    Kawamoto Y; Nakamura S; Matsuo A; Akiguchi I
    Acta Neuropathol; 2000 Aug; 100(2):131-7. PubMed ID: 10963359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of cells containing transforming growth factor-alpha precursor immunoreactivity in the basal ganglia of the adult rat brain.
    Fallon JH; Annis CM; Gentry LE; Twardzik DR; Loughlin SE
    Growth Factors; 1990; 2(2-3):241-50. PubMed ID: 2340185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrastriatal administration of human immunodeficiency virus-1 glycoprotein 120 reduces glial cell-line derived neurotrophic factor levels and causes apoptosis in the substantia nigra.
    Nosheny RL; Bachis A; Aden SA; De Bernardi MA; Mocchetti I
    J Neurobiol; 2006 Oct; 66(12):1311-21. PubMed ID: 16967504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.